- Home
- IOBT vs EDAP Comparison
IOBT vs EDAP Comparison
Compare IOBT & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- EDAP
- Stock Information
- Founded
- IOBT 2014
- EDAP 1979
- Country
- IOBT Denmark
- EDAP France
- Employees
- IOBT N/A
- EDAP N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IOBT Health Care
- EDAP Health Care
- Exchange
- IOBT Nasdaq
- EDAP Nasdaq
- Market Cap
- IOBT 50.5M
- EDAP 46.7M
- IPO Year
- IOBT 2021
- EDAP 1997
- Fundamental
- Price
- IOBT $0.87
- EDAP $2.18
- Analyst Decision
- IOBT Buy
- EDAP Buy
- Analyst Count
- IOBT 4
- EDAP 3
- Target Price
- IOBT $3.50
- EDAP $8.50
- AVG Volume (30 Days)
- IOBT 7.4M
- EDAP 71.3K
- Earning Date
- IOBT 11-07-2025
- EDAP 11-06-2025
- Dividend Yield
- IOBT N/A
- EDAP N/A
- EPS Growth
- IOBT N/A
- EDAP N/A
- EPS
- IOBT N/A
- EDAP N/A
- Revenue
- IOBT N/A
- EDAP $74,008,221.00
- Revenue This Year
- IOBT N/A
- EDAP N/A
- Revenue Next Year
- IOBT N/A
- EDAP N/A
- P/E Ratio
- IOBT N/A
- EDAP N/A
- Revenue Growth
- IOBT N/A
- EDAP 1.56
- 52 Week Low
- IOBT $0.32
- EDAP $1.21
- 52 Week High
- IOBT $2.79
- EDAP $3.05
- Technical
- Relative Strength Index (RSI)
- IOBT 47.19
- EDAP 47.63
- Support Level
- IOBT $0.62
- EDAP $1.75
- Resistance Level
- IOBT $1.23
- EDAP $2.44
- Average True Range (ATR)
- IOBT 0.14
- EDAP 0.25
- MACD
- IOBT 0.06
- EDAP -0.04
- Stochastic Oscillator
- IOBT 47.74
- EDAP 41.35
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.